Clinical trials: Female Sexual Arousal Disorder
Sexual Dysfunction, Physiological
The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.
CP-866,087 is a non-hormonal compound, acting on the central nervous system, which has been shown in animal models to restore sexual function.
- Trial name
- NCT00482664
- Testing
- CP-866,087
- Where
- 12 sites in Australia, Denmark and 3 more
- Volunteers
- 84 people
- Sponsor
- Pfizer
Sexual Arousal Disorder
Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.
- Trial name
- NCT00425256
- Testing
- Bremelanotide
- Where
- 20 sites in United States
- Sponsor
- Palatin Technologies, Inc
Sexual Dysfunction, Sexual Arousal Disorder
Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation.
The aim of this study to determine the effect of clitoral therapy device EROS device/ on sexual dysfunction after genital mutilation.
- Trial name
- NCT05039775
- Testing
- EROS device, Psychosexual support
- Where
- Egypt
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Badr University
Sexual Dysfunction
Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)
Tibolone has been registered for treatment of menopausal symptoms. It is, however, not known what the effects are of tibolone in postmenopausal women diagnosed with sexual dysfunction.
- Trial name
- NCT00413764
- Testing
- tibolone, estradiol-norethisterone
- Volunteers
- 358 people
- Sponsor
- Organon and Co
Sexual Arousal Disorder
Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
This is a Phase 2, single center, single-dose, double-blind, placebo-controlled, 2-way crossover study to evaluate the safety and efficacy of SST-6007 in women with FSAD.
- Trial name
- NCT02570282
- Testing
- SST-6007
- Where
- United States
- Volunteers
- 31 people
- Sponsor
- Strategic Science & Technologies, LLC
Female Sexual Dysfunction
the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction
The aim of this study is to evaluate the quality of sexual life of females with sexual interest or arousal disorder before and after accurate application of a formulated emulgel made from natural ingredients, including kaempferol…
- Trial name
- NCT06060691
- Testing
- Kaempferol
- Where
- Egypt
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Deraya University
Sexual Dysfunctions, Psychological
Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD).
This clinical trial is a prospective, randomized, double-blind Phase III study with two arms to determine the efficacy and safety of the use of an IPDE in women with FSIAD.
- Trial name
- FSIAD (NCT04433559)
- Testing
- Tadalafil 1,5 mg oral tablets
- Volunteers
- 80 people
- Sponsor
- Lidia Larrañaga
Sexual Dysfunction, Physiological
Topical Alprostadil for Female Sexual Arousal Disorder
Approximately 300 patients with female sexual arousal disorder who meet eligibility criteria will be enrolled and randomized to receive either active drug or matching placebo.
- Trial name
- NCT00324948
- Testing
- Topical alprostadil (PGE-1)
- Where
- 2 sites in United States
- Volunteers
- 300 people
- Sponsor
- VIVUS LLC
Hypoactive Sexual Desire Disorder
A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women
The purpose of this research study is to learn about sexual function in postmenopausal women and to determine whether the use of topical clitoral application of estradiol improves women's libido, arousal, and orgasmic ability.
- Trial name
- NCT02859285
- Testing
- Estradiol vulvar cream
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- ProHealth Care, Inc
Sexual Dysfunctions, Psychological, Sexual Arousal Disorder
An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
The purpose of this study is to evaluate the safety and toleration of oral sildenafil administered as required by women with Female Sexual Arousal Disorder (FSAD) who successfully complete one of the following Pfizer-sponsored…
- Trial name
- NCT00746967
- Testing
- sildenafil
- Where
- 82 sites in United States
- Volunteers
- 267 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Female Sexual Arousal Disorder
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
Antidepressants have negative effects on genital arousal function that hinder quality of life and jeopardize medication adherence.
- Trial name
- NCT05685407
- Testing
- Caffeine
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- University of Texas at Austin
Sexual Dysfunction, Physiological
Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women
This randomized, double-blind, placebo-controlled clinical trial investigated the effect of once daily oral administration of 20 mg estetrol monohydrate tablet for 12 weeks in postmenopausal women who experienced sexual arousal…
- Trial name
- NCT06308614
- Testing
- Estetrol
- Where
- 24 sites in United States
- Volunteers
- 82 people
- Sponsor
- Estetra
Female Sexual Arousal Disorder, Female Sexual Dysfunction (FSD)
Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder
Evaluation of the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder
- Trial name
- NCT06651541
- Testing
- BZ371A (0.5 ml), BZ371A (1.0 ml)
- Where
- Brazil
- Volunteers
- 174 people
- Sponsor
- Biozeus Biopharmaceutical S.A.
Female Sexual Arousal Disorder
Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder
The purpose of this study is to investigate the effect of 100 mg sildenafil on clitoral engorgement in pre-menopausal women, as well as examining the safety and toleration of the drug.
- Trial name
- NCT00640458
- Testing
- Sildenafil 100 mg
- Where
- 3 sites in United States, Australia
- Volunteers
- 20 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sexual Arousal Disorder
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
The goal of this clinical trial is to compare thermography images in normal healthy premenopausal women after the application of Sildenafil Cream, 3.6%, L-arginine cream, and placebo cream.
- Trial name
- NCT05765487
- Testing
- Sildenafil, Vehicle
- Where
- Canada
- Volunteers
- 13 people, healthy volunteers welcome
- Sponsor
- Daré Bioscience, Inc.
Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined), Sexual Interest/Arousal Disorder (DSM-5 Defined)
Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
The purpose of this study is to investigate whether Lorexys is effective and safe to treat premenopausal women who have lost their sexual desire to a distressing degree.
- Trial name
- PURPLE (NCT01857596)
- Testing
- bupropion, Lorexys low-dose, Lorexys moderate-dose
- Where
- 2 sites in United States
- Volunteers
- 30 people
- Sponsor
- S1 Biopharma, Inc.
Sexual Arousal Disorder, Sexual Desire Disorder
The Effectiveness of Online Interpersonal Relationships-Based Pyschoeducation in Increasing Sexual Interest and Arousal in Women With Sexual Interest and Arousal Disorder
This study will be conducted to examine the effectiveness of interpersonal relationships-based online psychoeducation developed for women with sexual interest and arousal disorders.
- Trial name
- NCT06445855
- Testing
- Interpersonal relationship-based intervention program
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Marmara University
Hypoactive Sexual Desire Disorder, Vulvovaginal Disease
Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
The regulation of clitoral vascularization by sex steroids is still under-investigated. We aimed to explore the effects of 6 months transdermal Testosterone (T) therapy on clitoral color Doppler ultrasound (CDU) parameters in…
- Conditions
- Hypoactive Sexual Desire Disorder, Vulvovaginal Disease, Menopause Related Conditions, Dyspareunia (Female Excluding Psychogenic)
- Trial name
- TESTOFSD (NCT04336891)
- Testing
- Testosterone gel, Estradiol ovules, Moisturizer
- Where
- Italy
- Volunteers
- 81 people
- Sponsor
- University of Florence
Female Sexual Arousal Disorder
Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
Low resting heart rate variability (HRV) has been associated with sexual arousal problems and overall sexual dysfunction in women.
- Trial name
- NCT02958176
- Testing
- HRV Biofeedback, Autogenic Training
- Where
- United States
- Volunteers
- 65 people
- Sponsor
- University of Texas at Austin
Female Sexual Dysfunction
Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction
Female sexual dysfunction (FSD) affects approximately one-third of women worldwide and is linked to negative physical, psychological, and interpersonal outcomes.
- Trial name
- NCT05168371
- Testing
- Cognitive-Behavioural Therapy - Online (CBT-O), Mindfulness-Based Therapy - Online (MBT-O)
- Where
- Canada
- Volunteers
- 129 people
- Sponsor
- University of British Columbia